Reading Time: 6 minutes On 29th September 2022 AMX0035, a treatment for Motor Neurone Disease (MND) was approved by the Food and Drug Administration (FDA) in the United States.
Month: September 2022
Reading Time: 2 minutes Hello, my name is Judith Bilgorai and I am a first year PhD student, funded by the MND Association, at King’s College London. I work